Page last updated: 2024-11-07

bimolane

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

bimolane: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID100708
CHEMBL ID488455
SCHEMBL ID9037099
MeSH IDM0098179

Synonyms (26)

Synonym
at-1727
nsc-351358
nsc351358
bimolane
2, 4,4'-(1,2-ethanediyl)bis[1-(4-morpholinylmethyl)-
74550-97-3
ccris 7574
4,4'-(1,2-ethanediyl)bis(1-(4-morpholinylmethyl)-2,6-piperazinedione)
nsc 351358
1,2-bis(4-morpholinomethyl-3,5-dioxopiperazinyl)-ethane
4,4'-ethylenebis(1-(morpholinomethyl)-2,6-piperazinedione)
2,6-piperazinedione, 4,4'-ethylenebis(1-(morpholinomethyl)-
1,2-bis(4-morpholinomethyl-3,5-dixoxpiperazinyl)ethane
1-(morpholin-4-ylmethyl)-4-[2-[4-(morpholin-4-ylmethyl)-3,5-dioxopiperazin-1-yl]ethyl]piperazine-2,6-dione
CHEMBL488455
25o7okr315 ,
unii-25o7okr315
2,6-piperazinedione, 4,4'-(1,2-ethanediyl)bis(1-(4-morpholinylmethyl)-
SCHEMBL9037099
DTXSID50225549
AKOS032947371
BCP18269
at1727;at 1727;bimolane; nsc 351358
Q27253986
HY-19437
CS-0015538

Research Excerpts

Overview

Bimolane is a member of the bis(2,6-dioxopiperazine) class of drugs. It has been widely used in China as an anti-neoplastic agent and for the treatment of psoriasis.

ExcerptReferenceRelevance
"Bimolane is a kind of genotoxic compound."( [Mutagenic effects of bimolane].
Chen, SQ; Ma, GJ; Wu, JZ; Xue, KX, 1995
)
2.05
"Bimolane is a member of the bis(2,6-dioxopiperazine) class of drugs and has been widely used in China as an anti-neoplastic agent and for the treatment of psoriasis. "( Bimolane: in vitro inhibitor of human topoisomerase II.
Eades, DM; Eastmond, DA; Frantz, CE; Grosovsky, AJ; Smith, H, 1997
)
3.18

Effects

Bimolane has been shown to have good antitumor activity. On an equitoxic basis its activity is usually better than the chemically related razoxane.

ExcerptReferenceRelevance
"Bimolane has been commonly used in China for the treatment of psoriasis and various types of cancer. "( Bimolane induces multiple types of chromosomal aberrations in human lymphocytes in vitro.
Eastmond, DA; Roy, SK, 2011
)
3.25
"Bimolane has been shown to have good antitumor activity and on an equitoxic basis its activity is usually better than the chemically related razoxane. "( Further evaluation of bimolane and analogs as potential antitumor agents.
Otter, GM; Ren, YF; Schmid, FA, 1985
)
2.03

Toxicity

ExcerptReferenceRelevance
" A study published in 1984 by Camerman and colleagues proposed that the therapeutic effects of bimolane could be due to ICRF-154, an impurity present within the bimolane samples that may also be responsible for the toxic effects attributed to bimolane."( A comparative study of the cytotoxic and genotoxic effects of ICRF-154 and bimolane, two catalytic inhibitors of topoisomerase II.
Eastmond, DA; Hasegawa, LS; Vuong, MC, 2013
)
0.84
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID409954Inhibition of mouse brain MAOA2008Journal of medicinal chemistry, Nov-13, Volume: 51, Issue:21
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (48.39)18.7374
1990's10 (32.26)18.2507
2000's1 (3.23)29.6817
2010's4 (12.90)24.3611
2020's1 (3.23)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.82

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.82 (24.57)
Research Supply Index3.50 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.82)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (3.23%)5.53%
Reviews1 (3.23%)6.00%
Case Studies2 (6.45%)4.05%
Observational0 (0.00%)0.25%
Other27 (87.10%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]